{
  "abstract": null,
  "abstract_shown": false,
  "affiliations": [
    "1National Institutes of Health, Bethesda, MD, USA",
    "Pediatric Oncology Branch, Center for Cancer Research, Bethesda, Maryland, USA",
    "National Cancer Institute, National Institutes of Health, Bethesda, MD, USA",
    "Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA"
  ],
  "article_type": null,
  "arxiv": null,
  "author_total": 7,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "Steven Highfill"
    },
    {
      "affs": [
        1
      ],
      "name": "Sabina Kaczanowska"
    },
    {
      "affs": [
        2
      ],
      "name": "Jessica Lake"
    },
    {
      "affs": [
        2
      ],
      "name": "Hong Lei"
    },
    {
      "affs": [
        2
      ],
      "name": "James L Gulley"
    },
    {
      "affs": [
        3
      ],
      "name": "Scott M Norberg"
    },
    {
      "affs": [
        2
      ],
      "name": "Rosandra N Kaplan"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/01npxk2nbrgwb.bib",
  "cited_by": 0,
  "doi": "10.1136/jitc-2026-sitc2026.0556",
  "fulltext_url": null,
  "id": "01npxk2nbrgwb",
  "issns": [
    "2051-1426"
  ],
  "landing_url": "https://doi.org/10.1136/jitc-2026-sitc2026.0556",
  "language": "en",
  "licence": "CC-BY",
  "licence_label": "CC BY",
  "licence_source": "journal",
  "licence_url": "https://creativecommons.org/licenses/by/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "lcc",
      "RC254-282"
    ]
  ],
  "openalex": null,
  "pdf_url": null,
  "pmcid": null,
  "pmid": null,
  "published": "2026-11-04",
  "publisher": "BMJ Publishing Group",
  "ris": "https://research.draconitic.com/paper/01npxk2nbrgwb.ris",
  "sources": [
    {
      "first_seen": "2026-11-05T14:21:13Z",
      "native_id": "51eedd12d2d94858866591e48ab7a16b",
      "source": "doaj",
      "url": "https://doi.org/10.1136/jitc-2026-sitc2026.0556"
    }
  ],
  "subjects": [
    {
      "field": "biology",
      "origin": "journal-openalex:2403|Immunotherapy and Immune Responses",
      "subfield": "immunology"
    },
    {
      "field": "medicine",
      "origin": "lcc:RC254-282",
      "subfield": "oncology"
    }
  ],
  "title": "556 A phase I first-in-human trial of IL-12 genetically engineered myeloid cells in participants with relapsed, refractory solid tumors",
  "title_text": "556 A phase I first-in-human trial of IL-12 genetically engineered myeloid cells in participants with relapsed, refractory solid tumors",
  "type": "peer-reviewed",
  "updated_at": "2026-11-06T14:20:42Z",
  "url": "https://research.draconitic.com/paper/01npxk2nbrgwb",
  "venue": "Journal for ImmunoTherapy of Cancer",
  "versions": []
}